Expert Blog | Beta Cells in Diabetes

Expert BlogBlog RSS

About the Blog

This forum allows a wide variety of leading researchers, endocrinologists, and primary care providers to expand informally on emerging research, case studies, and resources related to beta cells in diabetes, as well providing an opportunity for you to discuss and debate these issues.

Posts by Topic

Beta cell pathophysiology 14
DPP-4 inhibitors 7
GLP-1 agonists 12
Glycemic control 19
Insulin therapy 11
Lifestyle changes 8
Metformin 7
Prediabetes 5
Sulfonylureas (SUs) 5
Thiazolidinediones (TZDs) 12
Weight 5

Posts by Author

Aaron Kowalski, PhD 1
Carol Wysham, MD 1
Christopher J. Rhodes, PhD 2
Doron Schneider, MD, FACP 6
Eugene Wright, Jr., MD 2
Irl B. Hirsch, MD 6
Jennifer Larsen, MD 1
John L. Leahy, MD 4
Kevin A. Peterson, MD, MPH 6
Kim C. Dixon, MD 1
Patricia Brubaker, PhD 1
Robert H. Eckel, MD 1
Sonal Singh, MD, MPH 2

Patricia Brubaker, PhD
Basic Scientist

Professor and Associate Chair, Department of Physiology
Tier 1 Canada Research Chair in Vascular and Metabolic Biology
University of Toronto

Read the full biography

Incretin Therapy and Beta Cell Mass
Posted May 25, 2011 by Patricia Brubaker, PhD

Tags: beta cell pathophysiology, DPP-4 inhibitors, GLP-1 agonists

Analyses of human pancreata have demonstrated that type 2 diabetes is associated not only with a loss of beta cell function, but also with a marked decrease in beta cell volume.
- Continue Reading
- 0 Comments

Betacell

A resource for physicians established by the Endocrine Society

Text Size:

Expert BlogBlog RSS

About the Blog

Posts by Topic

Posts by Author

Incretin Therapy and Beta Cell Mass